CL2023000395A1 - Síntesis de compuestos de quinazolina. - Google Patents

Síntesis de compuestos de quinazolina.

Info

Publication number
CL2023000395A1
CL2023000395A1 CL2023000395A CL2023000395A CL2023000395A1 CL 2023000395 A1 CL2023000395 A1 CL 2023000395A1 CL 2023000395 A CL2023000395 A CL 2023000395A CL 2023000395 A CL2023000395 A CL 2023000395A CL 2023000395 A1 CL2023000395 A1 CL 2023000395A1
Authority
CL
Chile
Prior art keywords
synthesis
quinazoline compounds
compounds
quinazoline
atropisomeric
Prior art date
Application number
CL2023000395A
Other languages
English (en)
Inventor
Francis Gosselin
Haiming Zhang
Jie Xu
Ngiap-Kie Lim
Jeff Shen
Lauren Elizabeth Sirois
Jacob C Timmerman
Etienne Trachsel
Nicholas Andrew White
Stephan Bachmann
Raphael Bigler
Kyle Bradley Pascual Clagg
Antonio Giovanni Dipasquale
Roland Christoph Meier
Ugo Jonathan Orcel
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Publication of CL2023000395A1 publication Critical patent/CL2023000395A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

En la presente se proporcionan métodos para sintetizar compuestos de quinazolina que comprenden al menos un centro atropisomérico.
CL2023000395A 2020-08-12 2023-02-07 Síntesis de compuestos de quinazolina. CL2023000395A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063064746P 2020-08-12 2020-08-12

Publications (1)

Publication Number Publication Date
CL2023000395A1 true CL2023000395A1 (es) 2023-07-28

Family

ID=77543703

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2023000395A CL2023000395A1 (es) 2020-08-12 2023-02-07 Síntesis de compuestos de quinazolina.

Country Status (16)

Country Link
US (1) US20220081413A1 (es)
EP (1) EP4196470A1 (es)
JP (1) JP2023537999A (es)
KR (1) KR20230049679A (es)
CN (1) CN116057052A (es)
AR (1) AR123200A1 (es)
AU (2) AU2021325869C1 (es)
BR (1) BR112023002591A2 (es)
CA (1) CA3191001A1 (es)
CL (1) CL2023000395A1 (es)
CR (1) CR20230123A (es)
IL (1) IL300309A (es)
MX (1) MX2023001682A (es)
PE (1) PE20230733A1 (es)
TW (1) TWI829003B (es)
WO (1) WO2022035790A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150706A1 (en) * 2022-02-07 2023-08-10 Genentech, Inc. Solid forms of 1-((s)-4-((r)-7-(6-amino-4-methyl-3- (trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((s)-1- methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3- methylpiperazin-1-yl)prop-2-en-1-one

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010014005A (es) 2008-06-20 2011-02-15 Genentech Inc Compuestos de triazolopiridina inhibidores de jak y los metodos.
CN102686581B (zh) * 2009-12-21 2015-08-26 张强 喹唑啉衍生物
JP2013107855A (ja) * 2011-11-22 2013-06-06 Mitsubishi Tanabe Pharma Corp 医薬組成物
KR20160076519A (ko) * 2013-10-10 2016-06-30 아락세스 파마 엘엘씨 Kras g12c 억제제
US9988357B2 (en) * 2015-12-09 2018-06-05 Araxes Pharma Llc Methods for preparation of quinazoline derivatives
IL282916B1 (en) * 2018-11-09 2024-05-01 Hoffmann La Roche United Cyclic Chemical Compounds and Their Uses in the Treatment of RAS-Mediated Disorders

Also Published As

Publication number Publication date
PE20230733A1 (es) 2023-05-03
KR20230049679A (ko) 2023-04-13
WO2022035790A1 (en) 2022-02-17
TWI829003B (zh) 2024-01-11
IL300309A (en) 2023-04-01
US20220081413A1 (en) 2022-03-17
AU2024200220A1 (en) 2024-02-01
JP2023537999A (ja) 2023-09-06
AU2021325869C1 (en) 2024-05-30
AR123200A1 (es) 2022-11-09
CA3191001A1 (en) 2022-02-17
AU2021325869A1 (en) 2023-02-23
CR20230123A (es) 2023-04-19
CN116057052A (zh) 2023-05-02
EP4196470A1 (en) 2023-06-21
MX2023001682A (es) 2023-02-22
BR112023002591A2 (pt) 2023-04-04
TW202214596A (zh) 2022-04-16
AU2021325869B2 (en) 2024-02-15

Similar Documents

Publication Publication Date Title
CU20210080A7 (es) Triazinas sustituidas como inhibidores de proteína tirosina fosfatasa
AR122785A2 (es) Inhibidores de kras g12c y métodos para su uso
DOP2022000082A (es) Heterociclos bicíclicos como inhibidores de fgfr
CL2020001931A1 (es) Compuestos para el tratamiento de trastornos dependientes de cinasas.
CL2023000395A1 (es) Síntesis de compuestos de quinazolina.
BR112023017763A2 (pt) Inibidores kras g12d
CR10600A (es) Ciclopenta (d) pirimidinas hidroxiladas y metoxiladas como inhibidores de akt proteina quinasa
GT200200273A (es) Moleculas pequeñas para el tratamiento del crecimiento celular anormal
BR112022009390A2 (pt) Síntese melhorada de composto inibidor de kras g12c
EA201291246A1 (ru) Конденсированные бициклические ингибиторы киназы
BR112023017661A2 (pt) Inibidores de kras
AR122719A1 (es) Moléculas agonistas de unión al antígeno cd28 que se dirigen a her2
CL2020001930A1 (es) Compuestos para el tratamiento de trastornos dependientes de cinasas.
BR112022012512A2 (pt) Método para a preparação de l-glufosinato
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
ECSP23051657A (es) Nuevos compuestos como inhibidor dual del receptor de andrógenos y de la fosfodiesterasa
CL2020002217A1 (es) Uso de alcoxipirazoles como inhibidores de la nitrificación
MX2023006606A (es) Derivados biciclicos.
BR112022021899A2 (pt) Método para a síntese contínua de paracetamol
CO2023002375A2 (es) Anticuerpos contra ilt2 y uso de los mismos
CL2020002216A1 (es) Uso de compuestos de alcoxi pirazol funcionalizados con n como inhibidores de la nitrificación
CL2021002011A1 (es) Procedimiento para la reducción de olor de materiales de carbono en forma de partículas
CU20220019A7 (es) Proteínas de fusión nkg2d
CL2023001565A1 (es) Inhibidores de enzimas
EA202192840A1 (ru) Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты